BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/5/2026 9:54:29 AM | Browse: 1 | Download: 0
Publication Name World Journal of Hepatology
Manuscript ID 117382
Country China
Category Gastroenterology & Hepatology
Manuscript Type Letter to the Editor
Article Title Natural product intervention in metabolic dysfunction-associated steatotic liver disease: From allyl isothiocyanate to signaling networks
Manuscript Source Invited Manuscript
All Author List Rui Tian, Yi-Xin Wu, Jie-Yu Guo, Xing-Zhen Chen, Jing-Feng Tang and Ce-Fan Zhou
Funding Agency and Grant Number
Corresponding Author Ce-Fan Zhou, Professor, School of Life and Health Sciences, Institute of Biomedical Research, National “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, No. 28 Nanli Road, Wuhan 430068, Hubei Province, China. cefan@hbut.edu.cn
Key Words Allyl isothiocyanate; Metabolically-dysfunction-associated steatotic liver disease; Vitamin D receptor; Multitarget therapy; Network pharmacology
Core Tip This comment highlights that allyl isothiocyanate (AITC) illustrates the principle of multi-target natural product therapy for metabolic dysfunction-associated steatotic liver disease. Beyond the novel vitamin D receptor/hepatocyte nuclear factor 4 alpha pathway identified by Gao et al, we integrate this axis with established AITC targets, such as sirtuin 1/AMP-activated protein kinase, nuclear factor erythroid 2-related factor 2, to construct a multiple-signaling network. This network collectively reprograms lipid metabolism, insulin sensitivity, and oxidative stress. Future research must validate this integrative mechanism in vivo and leverage systems biology to advance AITC as a precise, network-based therapeutic strategy.
Citation Tian R, Wu YX, Guo JY, Chen XZ, Tang JF, Zhou CF. Natural product intervention in metabolic dysfunction-associated steatotic liver disease: From allyl isothiocyanate to signaling networks. World J Hepatol 2026; In press
Received
2025-12-08 00:49
Peer-Review Started
2025-12-08 00:49
First Decision by Editorial Office Director
2025-12-16 10:06
Return for Revision
2025-12-17 09:27
Revised
2025-12-25 09:57
Publication Fee Transferred
Second Decision by Editor
2026-02-05 02:37
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-02-05 09:54
Articles in Press
2026-02-05 09:54
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com